Loading…
The company announced the appointment on February 18, 2025.
ProPhase Labs, Inc. (OTC: PRPH) has appointed Stuart Hollenshead as its Chief Operating Officer, effective February 18, 2025. Hollenshead brings extensive experience in the pharmaceutical industry to his new role.
With a free float of 42,845,800 shares and 46,179,000 shares outstanding, ProPhase Labs continues to strengthen its executive team.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.